BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

599 related articles for article (PubMed ID: 21883892)

  • 1. Trichostatin A induces 5-lipoxygenase promoter activity and mRNA expression via inhibition of histone deacetylase 2 and 3.
    Pufahl L; Katryniok C; Schnur N; Sorg BL; Metzner J; Grez M; Steinhilber D
    J Cell Mol Med; 2012 Jul; 16(7):1461-73. PubMed ID: 21883892
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The histone deacetylase inhibitor trichostatin A mediates upregulation of 5-lipoxygenase promoter activity by recruitment of Sp1 to distinct GC-boxes.
    Schnur N; Seuter S; Katryniok C; Rådmark O; Steinhilber D
    Biochim Biophys Acta; 2007 Oct; 1771(10):1271-82. PubMed ID: 17894944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD1d induction in solid tumor cells by histone deacetylase inhibitors through inhibition of HDAC1/2 and activation of Sp1.
    Yang PM; Lin PJ; Chen CC
    Epigenetics; 2012 Apr; 7(4):390-9. PubMed ID: 22419072
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Silencing of transcription of the human luteinizing hormone receptor gene by histone deacetylase-mSin3A complex.
    Zhang Y; Dufau ML
    J Biol Chem; 2002 Sep; 277(36):33431-8. PubMed ID: 12091390
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histone deacetylase inhibitors modulate the transcriptional regulation of guanylyl cyclase/natriuretic peptide receptor-a gene: interactive roles of modified histones, histone acetyltransferase, p300, AND Sp1.
    Kumar P; Tripathi S; Pandey KN
    J Biol Chem; 2014 Mar; 289(10):6991-7002. PubMed ID: 24451378
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trichostatin A and structurally related histone deacetylase inhibitors induce 5-lipoxygenase promoter activity.
    Klan N; Seuter S; Schnur N; Jung M; Steinhilber D
    Biol Chem; 2003 May; 384(5):777-85. PubMed ID: 12817474
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histone deacetylase 1/mSin3A disrupts gamma interferon-induced CIITA function and major histocompatibility complex class II enhanceosome formation.
    Zika E; Greer SF; Zhu XS; Ting JP
    Mol Cell Biol; 2003 May; 23(9):3091-102. PubMed ID: 12697811
    [TBL] [Abstract][Full Text] [Related]  

  • 8. How to Distinguish Between the Activity of HDAC1-3 and HDAC6 with Western Blot.
    Beyer M; Kiweler N; Mahboobi S; Krämer OH
    Methods Mol Biol; 2017; 1510():355-364. PubMed ID: 27761834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inflammation-mediated deacetylation of the ribonuclease 1 promoter
    Bedenbender K; Scheller N; Fischer S; Leiting S; Preissner KT; Schmeck BT; Vollmeister E
    FASEB J; 2019 Aug; 33(8):9017-9029. PubMed ID: 31039328
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective inhibition of class I but not class IIb histone deacetylases exerts cardiac protection from ischemia reperfusion.
    Aune SE; Herr DJ; Mani SK; Menick DR
    J Mol Cell Cardiol; 2014 Jul; 72():138-45. PubMed ID: 24632412
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of intestinal serotonin transporter expression via epigenetic mechanisms: role of HDAC2.
    Gill RK; Kumar A; Malhotra P; Maher D; Singh V; Dudeja PK; Alrefai W; Saksena S
    Am J Physiol Cell Physiol; 2013 Feb; 304(4):C334-41. PubMed ID: 23195070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histone deacetylase inhibitors stimulate mitochondrial HMG-CoA synthase gene expression via a promoter proximal Sp1 site.
    Camarero N; Nadal A; Barrero MJ; Haro D; Marrero PF
    Nucleic Acids Res; 2003 Mar; 31(6):1693-703. PubMed ID: 12626711
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PSG gene expression is up-regulated by lysine acetylation involving histone and nonhistone proteins.
    Camolotto SA; Racca AC; Ridano ME; Genti-Raimondi S; Panzetta-Dutari GM
    PLoS One; 2013; 8(2):e55992. PubMed ID: 23418492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of 15-lipoxygenase-1 is regulated by histone acetylation in human colorectal carcinoma.
    Kamitani H; Taniura S; Ikawa H; Watanabe T; Kelavkar UP; Eling TE
    Carcinogenesis; 2001 Jan; 22(1):187-91. PubMed ID: 11159758
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of trichostatin A on neuronal mu-opioid receptor gene expression.
    Lin YC; Flock KE; Cook RJ; Hunkele AJ; Loh HH; Ko JL
    Brain Res; 2008 Dec; 1246():1-10. PubMed ID: 18950606
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trichostatin A, a histone deacetylase inhibitor, activates the IGFBP-3 promoter by upregulating Sp1 activity in hepatoma cells: alteration of the Sp1/Sp3/HDAC1 multiprotein complex.
    Choi HS; Lee JH; Park JG; Lee YI
    Biochem Biophys Res Commun; 2002 Aug; 296(4):1005-12. PubMed ID: 12200149
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-455-3p modulates cartilage development and degeneration through modification of histone H3 acetylation.
    Chen W; Chen L; Zhang Z; Meng F; Huang G; Sheng P; Zhang Z; Liao W
    Biochim Biophys Acta; 2016 Dec; 1863(12):2881-2891. PubMed ID: 27638301
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MS-275 inhibits aroclor 1254-induced SH-SY5Y neuronal cell toxicity by preventing the formation of the HDAC3/REST complex on the synapsin-1 promoter.
    Formisano L; Guida N; Laudati G; Mascolo L; Di Renzo G; Canzoniero LM
    J Pharmacol Exp Ther; 2015 Feb; 352(2):236-43. PubMed ID: 25467131
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HDAC inhibition activates the apoptosome via Apaf1 upregulation in hepatocellular carcinoma.
    Buurman R; Sandbothe M; Schlegelberger B; Skawran B
    Eur J Med Res; 2016 Jun; 21(1):26. PubMed ID: 27342975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of the growth-differentiation factor 11 gene by the histone deacetylase (HDAC) inhibitor trichostatin A and repression by HDAC3.
    Zhang X; Wharton W; Yuan Z; Tsai SC; Olashaw N; Seto E
    Mol Cell Biol; 2004 Jun; 24(12):5106-18. PubMed ID: 15169878
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.